Vantage Consulting Group’s Chemours CC Stock Holding History

Vantage Consulting Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-123	Closed	-$3K	–	351
2020 Q4	$3K	Buy	+123	New	+$2.93K	﹤0.01%	1542

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vantage Consulting Group's CC Position: Q1 2021 in Review

Vantage Consulting Group sold out of Chemours (CC) in Q1 2021, closing a stake of 123 shares — an estimated $3K sold.

Vantage Consulting Group first reported a position in CC in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 431 funds tracked by Wall St. Rank hold CC as of Q1 2021.

Vantage Consulting Group reported no remaining Chemours position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 123 Chemours shares in Q1 2021, an estimated $3K.
Vantage Consulting Group first reported a position in Chemours in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Chemours position peaked at $3K in Q4 2020.
431 funds tracked by Wall St. Rank held Chemours as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.